First Site Activated in the DE-ESCALATE Trial on Advanced Metastatic Prostate Cancer
Up to 1,600 patients are expected to be enrolled in this study across Europe. The clinical trial will be opened in 80 sites in the following 8 countries within the EORTC network (Belgium, Croatia, Czechia, Denmark, Italy, Portugal, Romania, Slovenia) and 30 sites across national networks in Ireland, France, and Spain.4The study is designed with […]
Dr Guillaume Grisay introduces the DE-ESCALATE trial
Watch this highly informative interview in which Dr Guillaume Grisay introduces the DE-ESCALATE trial in a conversation with Dr Alicia Morgans at GU ASCO 2024. GU ASCO stands for the 2024 American Society of Clinical Oncology Genitourinary cancers symposium held in San Francisco between January 25th and 27th. https://www.urotoday.com/video-lectures/prostate-cancer/video/3875-the-de-escalate-trial-intermittently-stopping-prostate-cancer-treatments-to-improve-quality-of-life-guillaume-grisay.html
